Neurizon Therapeutics LimitedASX: NUZ

Appendix 4C & Quarterly Update

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX ·

Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC 3000 Tel: +61 3 9692 7222 Quarterly Report & Appendix 4C: Q4 FY26 Highlights: Clinical and preclinical development activity · HEALEY ALS...

View Attachment

6ix hasn’t read this filing yet.

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases